9th Antifibrotic Drug Development Summit

This Event has Passed

Monday, November 17, 2025 - 8:30 AM
to Wednesday, November 19, 2025 - 3:30 PM

Add to Calendar

11/17/2025 08:30 AM 11/19/2025 03:30 PM America/Anguilla 9th Antifibrotic Drug Development Summit The antifibrotic field is at an inflection point: Madrigal’s Resmetirom secured the first-ever MASH approval in 2024, Boehringer’s nerandomilast hit its Phase 3 endpoint in IPF, and pharma giants like Lilly and GSK are investing billions in fibrosis pipelines. Yet, with GLP-1s reshaping metabolic disease treatment and organ-specific challenges persisting, developers must now prove differentiation, whether through novel targets, biomarker strategies, or pan-fibrotic mechanisms. Tackle these shared challenges alongside 80+ leaders from Pfizer, Novartis, Gilead Sciences, and pioneering biotechs at the 9th Antifibrotic Drug Development Summit - the only cross-fibrosis industry summit bridging di... Details & Tickets: https://www.upcomingevents.com/boston/events/wyndham-boston-beacon-hill/9th-antifibrotic-drug-development-summit-500047?ref=uceaddevent Wyndham Boston Beacon Hill, 5 Blossom Street, Boston, MA, 02114

Neighborhoods

Beacon Hill (Boston)
Downtown Crossing (Boston)
Government Center (Boston)
West End (Boston)

View Event Website »

The antifibrotic field is at an inflection point: Madrigal’s Resmetirom secured the first-ever MASH approval in 2024, Boehringer’s nerandomilast hit its Phase 3 endpoint in IPF, and pharma giants like Lilly and GSK are investing billions in fibrosis pipelines. Yet, with GLP-1s reshaping metabolic disease treatment and organ-specific challenges persisting, developers must now prove differentiation, whether through novel targets, biomarker strategies, or pan-fibrotic mechanisms. Tackle these shared challenges alongside 80+ leaders from Pfizer, Novartis, Gilead Sciences, and pioneering biotechs at the 9th Antifibrotic Drug Development Summit - the only cross-fibrosis industry summit bridging discovery to Phase 2, across IPF, MASH, kidney, cardiac, and systemic sclerosis fibrosis.

Event Links

Brochure: https://go.evvnt.com/3178913-0

Website: https://go.evvnt.com/3178913-1

Tickets: https://go.evvnt.com/3178913-3

View Less